MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL)
CUSIP: 558868105
Q4 2016 13F Holders as of 31 Dec 2016
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 22,766,960
- Total 13F shares
- 1,345,552
- Share change
- +338,576
- Total reported value
- $20,048,209
- Price per share
- $14.90
- Number of holders
- 24
- Value change
- +$6,295,667
- Number of buys
- 11
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 558868105?
CUSIP 558868105 identifies MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 558868105:
Top shareholders of MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| CAXTON CORP |
13F
|
Company |
2.2%
|
506,738
|
$6,425,000 | — | 30 Sep 2016 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
0.58%
|
132,000
|
$1,674,000 | — | 30 Sep 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.45%
|
101,833
|
$1,291,000 | — | 30 Sep 2016 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.28%
|
63,000
|
$799,000 | — | 30 Sep 2016 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.25%
|
57,762
|
$732,000 | — | 30 Sep 2016 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.23%
|
52,987
|
$672,000 | — | 30 Sep 2016 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.12%
|
26,202
|
$332,000 | — | 30 Sep 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.08%
|
18,317
|
$232,000 | — | 30 Sep 2016 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.07%
|
16,202
|
$205,000 | — | 30 Sep 2016 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.05%
|
12,043
|
$153,000 | — | 30 Sep 2016 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
0.05%
|
11,195
|
$142,000 | — | 30 Sep 2016 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.01%
|
3,279
|
$42,000 | — | 30 Sep 2016 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.01%
|
1,824
|
$23,000 | — | 30 Sep 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
0%
|
632
|
$8,000 | — | 30 Sep 2016 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0%
|
558
|
$7,000 | — | 30 Sep 2016 | |
| Cutler Group LLC / CA |
13F
|
Company |
0%
|
547
|
$6,000 | — | 30 Sep 2016 | |
| Evercore Wealth Management, LLC |
13F
|
Company |
0%
|
354
|
$4,000 | — | 30 Sep 2016 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
341
|
$4,000 | — | 30 Sep 2016 | |
| Creative Planning |
13F
|
Company |
0%
|
312
|
$4,000 | — | 30 Sep 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
250
|
$3,000 | — | 30 Sep 2016 | |
| Advisor Group, Inc. |
13F
|
Company |
0%
|
228
|
$3,000 | — | 30 Sep 2016 | |
| UBS Group AG |
13F
|
Company |
0%
|
142
|
$2,000 | — | 30 Sep 2016 | |
| Vantage Investment Advisors, LLC |
13F
|
Company |
0%
|
128
|
$2,000 | — | 30 Sep 2016 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
128
|
$2,000 | — | 30 Sep 2016 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
88
|
$1,000 | — | 30 Sep 2016 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0%
|
42
|
$1,000 | — | 30 Sep 2016 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
42
|
$1,000 | — | 30 Sep 2016 |
Institutional Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) as of Q4 2016
As of 31 Dec 2016,
MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,345,552 shares.
The largest 10 holders included
Capital World Investors, ADAGE CAPITAL PARTNERS GP, L.L.C., Rock Springs Capital Management LP, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Institutional Trust Company, N.A., and Paloma Partners Management Co.
This page lists
24
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2016 vs Q3 2016 Across Filers
Q3 2016 holders
24
Q4 2016 holders
24
Holder diff
0
| Investor | Q3 2016 Shares | Q4 2016 Shares | Share Diff | Share Chg % | Q3 2016 Value $ | Q4 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.